• Note d'application

Trazodone

Trazodone

  • Waters Corporation

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief demonstrates analysis of trazodone.

Introduction

The compounds used in this study are – 

Compounds

USP Tailing Factors

1-(3-chlorophenyl)peperazine

1.31

Maprotiline (I.S.)

1.21

Trazodone

1.12

Experimental

HPLC Method

Column:

Symmetry Shield RP8, 3.9 x 150 mm, 5 μm

Part numbers:

WAT200655

Mobile phase:

50 mM phosphate, pH7.0/methanol 36:64

Flow rate:

1.0 mL/min

Injection volume:

25 μL

Detection:

UV @ 250 nm

Results and Discussion

Featured Products

WA31763.171, June 2003

Haut de la page Haut de la page